Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.
Jesper van BreeschotenAlfonsus J M van den EertweghLiesbeth C de WreedeDoranne L HilariusErik W van ZwetJohn B HaanenChristian U BlankMaureen J B AartsFranchette W P J van den BerkmortelJan Willem B de GrootGeke A P HospersEllen H W KapiteijnDjura PiersmaRozemarijn S van RijnMarion A M Stevense-den BoerAstrid A M van der VeldtGerard VreugdenhilMarye J Boers-SonderenKarlijn P M SuijkerbuijkMichel W J M WoutersPublished in: Cancers (2021)
Our data suggest that between 2014 and 2015, after correcting for patient case-mix, significant variation in 2-year survival probabilities between Dutch melanoma centers existed. The use of new systemic therapies could partially explain this variation. In 2013 and between 2016 and 2017, no significant variation between centers existed.